These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2789299)

  • 1. Comparison of the effects of MCI-154, a new cardiotonic agent, and some Ca2+-sensitizing agents on the response of the contractile system to Ca2+ in skinned cardiac muscle.
    Kitada Y; Morita M; Narimatsu A
    Jpn J Pharmacol; 1989 Aug; 50(4):411-9. PubMed ID: 2789299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles.
    Kitada Y; Narimatsu A; Matsumura N; Endo M
    J Pharmacol Exp Ther; 1987 Nov; 243(2):633-8. PubMed ID: 3500301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.
    Kitada Y; Abe Y; Narimatsu A; Tobe A
    J Pharmacol Exp Ther; 1991 May; 257(2):812-9. PubMed ID: 2033522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
    Fujino K; Sperelakis N; Solaro RJ
    Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sulmazole and pimobendan on contractility of skinned fibres from frog skeletal muscle.
    Piazzesi G; Morano I; Rüegg JC
    Arzneimittelforschung; 1987 Oct; 37(10):1141-3. PubMed ID: 3435586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contractile proteins: possible targets for the cardiotonic action of MCI-154, a novel cardiotonic agent?
    Kitada Y; Narimatsu A; Matsumura N; Endo M
    Eur J Pharmacol; 1987 Feb; 134(2):229-31. PubMed ID: 3569412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCI-154, a cardiac Ca2+ sensitizer, reverses the depression in maximal Ca2+-activated force by inorganic phosphate and acidic pH in skinned fiber of guinea pig heart.
    Kitada Y
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):611-8. PubMed ID: 9493698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac profile of EGIS-9377, a novel cardiotonic agent as a Ca2+ sensitizer with bradycardiac activity.
    Hattori Y; Ishitani T; Tomita F; Gando S; Yokoshiki H; Azuma M; Kemmotsu O; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):585-90. PubMed ID: 10598798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimobendan increases calcium sensitivity of skinned human papillary muscle fibers.
    Scheld HH; Fritsche R; Schlepper M; van Meel JC
    J Clin Pharmacol; 1989 Apr; 29(4):360-6. PubMed ID: 2723124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pimobendan, a novel inotropic agent, on intracellular calcium and tension in isolated ferret ventricular muscle.
    Lee JA; Ruegg JC; Allen DG
    Clin Sci (Lond); 1989 Jun; 76(6):609-18. PubMed ID: 2544344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-sensitivity modulation of cardiac myofibrillar proteins.
    Rüegg JC; Morano I
    J Cardiovasc Pharmacol; 1989; 14 Suppl 3():S20-3. PubMed ID: 2478799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The positive inotropic effect of pimobendan involves stereospecific increases in the calcium sensitivity of cardiac myofilaments.
    Solaro RJ; Fujino K; Sperelakis N
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S7-12. PubMed ID: 2478795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig hearts.
    Bethke T; Brunkhorst D; von der Leyen H; Meyer W; Nigbur R; Scholz H
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):576-82. PubMed ID: 2457816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of MCI-154, a calcium sensitizer, on calcium sensitivity of myocardial fibers in endotoxic shock rats.
    Ming MJ; Hu D; Chen HS; Liu LM; Nan X; Hua CH; Lu RQ
    Shock; 2000 Dec; 14(6):652-6. PubMed ID: 11131917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".
    Beier N; Harting J; Jonas R; Klockow M; Lues I; Haeusler G
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):17-27. PubMed ID: 1719287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pimobendan on the L-type Ca2+ current and developed tension in guinea-pig ventricular myocytes and papillary muscle: comparison with IBMX, milrinone, and cilostazol.
    Matsui K; Kiyosue T; Wang JC; Dohi K; Arita M
    Cardiovasc Drugs Ther; 1999 Apr; 13(2):105-13. PubMed ID: 10372225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MCI-154 on Ca2+ activation of skinned human myocardium.
    Perreault CL; Brozovich FV; Ransil BJ; Morgan JP
    Eur J Pharmacol; 1989 Jun; 165(2-3):305-8. PubMed ID: 2776833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in membrane potentials and currents of ventricular cells of the guinea pig heart by a new cardiotonic drug, MCI-154.
    Katayama S; Narimatsu A; Suzuki R; Iijima T; Taira N
    Jpn J Pharmacol; 1987 Aug; 44(4):481-8. PubMed ID: 3682412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+-sensitizing effect of BM 14.478 on skinned cardiac muscle fibres of guinea-pig papillary muscle.
    Freund P; Müller-Beckmann B; Strein K; Kling L; Rüegg JC
    Eur J Pharmacol; 1987 Apr; 136(2):243-6. PubMed ID: 3595723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.